As violence escalates in Gaza, Al Jazeera Mubasher correspondent Hossam Shabat was killed today in an Israeli airstrike targeting his car in Jabalia. Shabat, aged 23, is among several journalists who have lost their lives in the ongoing conflict, as well as Mohamed Mansour, a correspondent for the TV channel Palestine Today, who was killed in a separate airstrike south of Khan Younis on Monday, 24 March. Al Jazeera Media Network has issued a strong condemnation of the attack, reiterating its commitment to pursue legal action against those responsible for the killing of journalists. The network highlighted that more than 200 journalists have been killed in Gaza since the conflict intensified in October 2023. Al Jazeera expressed its condolences to Shabat’s family and called on human rights organizations to denounce the systematic targeting of journalists under international humanitarian law. The non-profit organization Committee to Protect Journalists (CPJ) has also condemned these killings and urged the international community to act swiftly to ensure the safety of journalists in conflict zones. The CPJ noted that attacks on journalists are illegal, as they are considered civilians during wartime. The recent airstrikes coincide with…
This content is for members only. Visit the site and log in/register to read.Al Jazeera Correspondent Hossam Shabat Killed in Gaza Airstrike first appeared on Egyptian Streets.
Hence then, the article about al jazeera correspondent hossam shabat killed in gaza airstrike was published today ( ) and is available on Egyptian Streets ( Egypt ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Al Jazeera Correspondent Hossam Shabat Killed in Gaza Airstrike )
Also on site :
- Golfer Masashi ‘Jumbo’ Ozaki dies at 78
- Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
- Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline